Pelthos Therapeutics Inc. Payments for Repurchase of Equity
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- Pelthos Therapeutics Inc. payments for repurchase of equity for the quarter ending 2024-12-31 was -$74.49K.
- Pelthos Therapeutics Inc. payments for repurchase of equity for the quarter ending 2024-09-30 was $74.49K.
- Pelthos Therapeutics Inc. payments for repurchase of equity for the quarter ending 2024-06-30 was $0.00.
- Pelthos Therapeutics Inc. payments for repurchase of equity for the quarter ending 2024-03-31 was $91.51K.
- Pelthos Therapeutics Inc. payments for repurchase of equity for fiscal 2024 was $91.51K.
| Period end | Payments for Repurchase of Equity 3 month | Payments for Repurchase of Equity 12 month |
|---|---|---|
| 2024-12-31 | -$74.49K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $91.51K 10-K · filed 2025-03-27 |
| 2024-09-30 | $74.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | |
| 2024-03-31 | $91.51K 10-Q · filed 2025-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |